Regorafenib ≥98% (by HPLC)
Supplier: ADIPOGEN CORP MS
|
Warning
|
Synonyms:
4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide, BAY-73-4506
AG-CR1-3623-M005
AG-CR1-3623-M025
102988-806EA
48.46
USD
102988-806
102988-808
Regorafenib ≥98% (by HPLC)
Regorafenib
Orally bioavailable potent antitumor, antiangiogenic, antiproliferative and antineoplastic agent. Multi-target kinase inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRbeta, Kit, RET and Raf-1 with IC50 values of 13, 4.2, 46, 22, 7, 1.5 and 2.5nM, respectively.
Formula:
C₂₁H₁₅ClF₄N₄O₃ MW: 482.8 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD16038047 CAS Number: 755037-03-7 |
Specification Test Results
Purity |
|
Appearance/Color | Light pink to white solid. |
Solubility |
Soluble in DMSO ( |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...